FDA draft guidance on transdermal systems [BE/BA News]

posted by Ohlbe – France, 2023-04-13 10:37 (468 d 16:50 ago) – Posting: # 23523
Views: 1,315

Dear all,

If you're working on transdermal and topical delivery systems, you will be interested in two new FDA draft guidance documents:
- one on the assessment of irritation and sensitisation potential;
- one on the assessment of adhesion.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,127 posts in 4,859 threads, 1,646 registered users;
82 visitors (0 registered, 82 guests [including 13 identified bots]).
Forum time: 03:27 CEST (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5